Nicotine Withdrawal Symptoms: What to Expect and When

Nicotine withdrawal is a well-characterized clinical phenomenon. The DSM-5 lists its diagnostic criteria: irritability, anxiety, difficulty concentrating, increased appetite, restlessness, depressed mood, and insomnia, appearing within 24 hours of cessation and causing clinically significant distress [5]. Not everyone experiences all of these. What almost everyone experiences is cravings. Understanding the specific symptoms, their timeline and their relative contribution to relapse risk is practically useful for anyone planning a quit attempt.

The withdrawal timeline

The timeline is well established from prospective studies [1] [2]:

Hours 4-24: Cravings begin. Irritability and restlessness appear. Many people report difficulty concentrating by the end of the first day. These are not psychological: they are the pharmacological consequence of nicotine receptors that were chronically stimulated suddenly receiving no agonist. Nicotine’s half-life is roughly two hours, so by four to six hours after the last cigarette, blood nicotine levels have dropped substantially and the receptors begin signaling their deficit.

Days 1-3: Symptoms intensify. Irritability and anxiety typically peak during this window. Sleep disturbance is common, with difficulty falling asleep or fragmented sleep. Appetite increases as nicotine’s appetite-suppressing effect lifts. Many people describe a sense of restlessness that is difficult to sit with: a feeling of needing to do something without knowing what.

Days 3-5: The peak of physical withdrawal for most people. This is the window in which relapse risk is highest [3]. Concentration difficulties are pronounced. The feeling is often described as a fog or restlessness that makes sustained focus difficult. Irritability may reach its most intense point during this period, and for some people, a distinct depressed mood emerges that was not present in the first two days.

Days 5-14: Gradual improvement. Most physical symptoms begin to ease. Cravings become less constant, though individual cravings can still be intense. Sleep patterns begin to normalize. The concentration difficulties that were severe in the first week usually improve noticeably, though some people report a lingering fogginess that takes another week or two to fully clear.

Weeks 2-4: Most physical withdrawal symptoms have resolved or diminished significantly. Appetite changes and cravings persist. Cravings shift from a near-constant background pull to episodic triggers: after a meal, with coffee, in social situations where you used to smoke. This shift in craving character is an important sign of progress, even though the individual cravings that do occur can still feel strong.

Months 1-3 and beyond: Cravings continue but are typically briefer and less frequent. Ecological momentary assessment studies show that individual cravings at this stage last minutes, not hours [6]. The triggers become more predictable and more manageable, though they can catch people by surprise months after quitting. A smell, a particular kind of stress, returning to a place associated with smoking: these contextual cues can produce a craving that feels disproportionately strong relative to how long ago the person quit.

The symptom-by-symptom picture

Cravings. The defining symptom of nicotine withdrawal. Cravings are both tonic (a constant background urge during the first week) and phasic (acute spikes triggered by specific situations). The tonic component fades within two to four weeks. The phasic component persists longer, because it is driven by conditioned associations between smoking and specific contexts rather than by receptor-level nicotine deficit. An individual craving typically peaks within three to five minutes and then subsides, a fact that is practically useful for getting through them.

Irritability and anger. Among the most commonly reported symptoms and among the most disruptive to daily life. Irritability typically peaks in the first three to five days and diminishes over two to three weeks. It is driven by the abrupt reduction in dopamine and norepinephrine signaling that nicotine maintained. People around the quitter often notice the irritability before the quitter does.

Anxiety. Nicotine has anxiolytic effects through its interaction with GABAergic systems. Withdrawal temporarily reverses this, producing elevated anxiety that can range from a low-level background tension to something more intense in people with pre-existing anxiety conditions. The anxiety component usually resolves within two to four weeks.

Difficulty concentrating. Nicotine enhances cognitive performance through cholinergic receptor activation in the prefrontal cortex. Withdrawal impairs sustained attention and working memory. The concentration difficulties peak in the first week and typically resolve by week three, though some cognitive fog may persist for a few weeks beyond that. For people whose work requires sustained focus, this is one of the most practically disruptive symptoms.

Increased appetite and weight gain. Nicotine increases resting metabolic rate by roughly 7-15% and suppresses appetite. Withdrawal reverses both effects simultaneously. The result is a caloric surplus that produces an average weight gain of 4-5 kg over the first year. This is covered in detail in the post on post-cessation weight gain.

Sleep disturbance. Both insomnia and hypersomnia are reported during withdrawal. The pattern varies: some people have difficulty falling asleep, others wake frequently, and some experience increased total sleep time with a feeling of fatigue during the day. Sleep disturbances are usually most pronounced in the first week and normalize by weeks two to three.

Depressed mood. A transient depressed mood during withdrawal is common and is distinct from clinical depression, though it can be more severe in people with a history of depressive episodes. The mood disturbance typically resolves within two to four weeks. For smokers with a history of depression, a prescriber conversation about whether bupropion (which treats both depression and nicotine dependence) is appropriate can be valuable.

Which symptoms matter most for relapse

Not all withdrawal symptoms contribute equally to relapse risk. Cravings and negative affect (irritability, anxiety, depressed mood) are the strongest predictors of early relapse [3]. Difficulty concentrating is distressing but less consistently linked to relapse. Weight gain is a common reason people resume smoking weeks or months after the acute withdrawal period.

The distinction matters for choosing a quit method. NRT reduces cravings and irritability by maintaining some nicotine input. Varenicline reduces cravings through partial receptor agonism and also blunts the reward from any cigarettes smoked during the quit attempt [4]. Bupropion appears to reduce negative affect more than cravings per se, which may explain its particular usefulness for smokers with co-occurring depression.

Individual variation

Withdrawal severity varies substantially between people. Heavier smokers, those who smoke within 30 minutes of waking, and people with higher scores on the Fagerstrom Test for Nicotine Dependence tend to experience more severe withdrawal [1]. But individual variation is large even within these groups. Some heavy smokers experience mild withdrawal; some lighter smokers find it severe.

The pattern of prior quit attempts also matters. People who have relapsed during the first week in previous attempts often expect the same pattern, and pharmacological support can change it meaningfully. The withdrawal of a patch-supported quit attempt feels different from cold-turkey withdrawal: less acute, more manageable, though not absent. Understanding this difference can shift the expectation from “withdrawal is something to endure” to “withdrawal is something to manage with the right tools.”

Genetics also play a role that is not yet clinically actionable. Variations in the CYP2A6 gene, which codes for the enzyme that metabolizes nicotine, affect how quickly the body clears nicotine. Faster metabolizers tend to smoke more, experience more intense withdrawal, and have lower quit rates. This is a research finding, not yet a basis for individualized treatment, but it underlines that withdrawal severity is biological, not a character measure.

How quit methods change withdrawal

Method	Effect on withdrawal	Notes
Cold turkey	Full withdrawal, unmodified	Peak days 3-5, most symptoms resolve by week 4
Nicotine patch	Reduces baseline cravings, irritability	Does not cover acute craving spikes
Nicotine gum/lozenge	Reduces acute cravings on demand	Requires active use; technique matters
Combination NRT	Reduces both baseline and acute cravings	Most complete NRT coverage
Varenicline	Reduces cravings and blunts reward from smoking	Different withdrawal character than NRT
Bupropion	Reduces negative affect, some craving reduction	May be particularly useful for co-occurring depression

The table illustrates an important point: different methods address different components of withdrawal. The patch covers the baseline; gum or lozenge covers the spikes; combination NRT covers both. Varenicline changes the experience through a different mechanism entirely: by partially occupying the nicotine receptor, it both reduces the craving signal and makes any cigarettes smoked during the quit attempt less rewarding [4]. This dual action is part of why varenicline has the highest single-method quit rates.

What this means if you’re deciding

Understanding the withdrawal timeline is practically useful for planning a quit attempt. The first five days are the hardest for most people, and having support in place before that window, not after, improves outcomes. “I’ll see how I feel and then decide about the patch” is a common plan, and it is backwards: pharmacological support works best when it is in place from the start, not added as rescue.

If you have tried to quit before and found the withdrawal intolerable, that is useful information about your level of nicotine dependence, not evidence that you lack willpower. It is an indication for pharmacological support, preferably combination NRT or varenicline, which change the withdrawal experience significantly [4].

For smokers with COPD, withdrawal symptoms are the same, but the clinical motivation to push through them is stronger. The benefit of quitting in COPD is substantial enough that using the highest-efficacy method to get through the withdrawal period is worth the prescription conversation. The GOLD guidelines recommend cessation pharmacotherapy at every stage of COPD, and the Lung Health Study demonstrated that sustained cessation slows lung function decline to near-normal rates.

Open questions

Why some people experience prolonged withdrawal symptoms beyond the typical two-to-four-week window is not fully understood. Some researchers have proposed that individual differences in nicotine metabolism (CYP2A6 variants) influence both dependence severity and withdrawal duration, but the clinical evidence for tailoring quit methods by metabolizer status is still preliminary [1]. Whether withdrawal severity can be reliably predicted before a quit attempt in a way that guides method selection is an open question with practical implications: if clinicians could identify in advance which smokers will have severe withdrawal, they could recommend higher-efficacy methods from the start rather than having people fail on lower-intensity approaches first.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.